Cargando…
A concept of eliminating nonhomologous recombination for scalable and safe AAV vector generation for human gene therapy
Scalable and efficient production of high-quality recombinant adeno-associated virus (rAAV) for gene therapy remains a challenge despite recent clinical successes. We developed a new strategy for scalable and efficient rAAV production by sequestering the AAV helper genes and the rAAV vector DNA in t...
Autores principales: | Dong, Biao, Moore, Andrea R., Dai, Jihong, Roberts, Sean, Chu, Kirk, Kapranov, Philipp, Moss, Bernard, Xiao, Weidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711426/ https://www.ncbi.nlm.nih.gov/pubmed/23677609 http://dx.doi.org/10.1093/nar/gkt404 |
Ejemplares similares
-
Identification of eukaryotic promoter regulatory elements using nonhomologous random recombination
por: Doyon, Jeffrey B., et al.
Publicado: (2007) -
Proteomics Analysis of Co-Purifying Cellular Proteins Associated with rAAV Vectors
por: Dong, Biao, et al.
Publicado: (2014) -
Ultrafiltered recombinant AAV8 vector can be safely administered in vivo and efficiently transduces liver
por: Kleven, Mark D., et al.
Publicado: (2018) -
Cas9-induced nonhomologous recombination in C. elegans
por: Zdraljevic, Stefan, et al.
Publicado: (2023) -
Scalable Production of AAV Vectors in Orbitally Shaken HEK293 Cells
por: Blessing, Daniel, et al.
Publicado: (2018)